Ear and Head Tumors
Ear and Head Tumors is a research topic within Oncology. Science Explorer counts 18k research works in it since 1950. 7.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on various types of tumors affecting the ear and temporal bone, including squamous cell carcinoma, endolymphatic sac tumors, middle ear adenomas, and carcinoid tumors. The papers discuss the clinical features, management outcomes, treatment strategies such as chemoradiotherapy and surgical resection, as well as the implications of von Hippel-Lindau disease on these tumors.
- Ear Tumors
- Temporal Bone Carcinoma
- Squamous Cell Carcinoma
- Endolymphatic Sac Tumors
- von Hippel-Lindau Disease
- Middle Ear Adenoma
- Carcinoid Tumor
- Chemoradiotherapy
- Surgical Management
- Metastases
- Research works
- 18k fractional, since 1950
- In the world top 10%
- 1.3k per year above
- Top-10% rate
- 7.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +15% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ear and Head Tumors research?
By volume, the United States and India publish the most (505 and 350 works in 2022–2025).
By volume, 2022–2025
- 1 United States 505 works
- 2 India 350 works
- 3 China 278 works
- 4 Japan 239 works
- 5 Germany 119 works
- 6 Italy 95 works
- 7 South Korea 70 works
- 8 United Kingdom 69 works
- 9 Brazil 62 works
- 10 Türkiye 59 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ear and Head Tumors research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Ear and Head Tumors research, followed by The University of Texas MD Anderson Cancer Center and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 16 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 13 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 13 works
- 4 Institute of Medical SciencesIndia 10 works
- 5 Eye & ENT Hospital of Fudan UniversityChina 9 works
- 6 Memorial Sloan Kettering Cancer CenterUnited States 9 works
- 7 Harvard UniversityUnited States 8 works
- 8 Emory UniversityUnited States 8 works
- 9 Alexandria UniversityEgypt 8 works
- 10 Universitätsklinik für Hals-, Nasen- und OhrenheilkundeGermany 7 works
Where is Ear and Head Tumors research done?
The largest centres of Ear and Head Tumors research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and New Delhi (India).
Largest cities, 2022–2025
Where is the best place to study Ear and Head Tumors?
Among universities, judged by research, All India Institute of Medical Sciences, Institute of Medical Sciences and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical SciencesIndia | 58.9 | 0.4% | 10.4× | 16 | +83.6% |
| 2 | Institute of Medical SciencesIndia | 48.6 | 0.0% | 13.3× | 10 | +95.5% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 40.6 | 8.7% | 5.4× | 13 | +24.5% |
| 4 | Harvard UniversityUnited States | 33.4 | 16.4% | 2.7× | 8 | +23.2% |
| 5 | Emory UniversityUnited States | 18.0 | 5.2% | 4.9× | 8 | -2.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Ear and Head Tumors research growing?
Output in 2018–2022 was 15% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Ear and Head Tumors.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.